Rhodojaponin VI is a diterpenoid compound that primarily targets the N-Ethylmaleimide-sensitive fusion protein (NSF). It exhibits significant biological activity by blocking the MDM2-Notch1 signaling pathway, thereby reducing the expression of MDM2 and Notch1, and inhibits NSF-mediated Cav2.2 trafficking, leading to decreased Cav2.2 current intensity. Rhodojaponin VI demonstrates therapeutic potential in alleviating glomerulonephritis progression and protecting against podocyte injury in passive Heymann nephritis models. Additionally, it possesses antinociceptive properties, making it a valuable reagent for research in nephritis and pain mechanisms.
Rhodojaponin VI is a diterpenoid compound that primarily targets the N-Ethylmaleimide-sensitive fusion protein (NSF). It exhibits significant biological activity by blocking the MDM2-Notch1 signaling pathway, thereby reducing the expression of MDM2 and Notch1, and inhibits NSF-mediated Cav2.2 trafficking, leading to decreased Cav2.2 current intensity. Rhodojaponin VI demonstrates therapeutic potential in alleviating glomerulonephritis progression and protecting against podocyte injury in passive Heymann nephritis models. Additionally, it possesses antinociceptive properties, making it a valuable reagent for research in nephritis and pain mechanisms.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
